Announcements / 06.14.22
July 12: LatinX@Broad Speaker Series | Indigenous Biomarkers, Bioethics, and Biobanks,

Register and join us for our next talk: Krystal Tsosie, Vanderbilt University, presenting Indigenous Biomarkers, Bioethics, and Biobanks.

Image
LatinX@Broad 2022 Speaker Series


View past talks on YouTube.

 

Upcoming Talks

All talks will be recorded and open to the public.

July 12, 2022
2:00 p.m. − 3:00 p.m. EST
Krystal Tsosie
Vanderbilt University
Indigenous Biomarkers, Bioethics, and Biobanks
Krystal Tsosie research focuses on pre-eclampsia (PE) which is defined by the onset of high blood pressure and excess excretion of protein in urine during mid-to late stages of pregnancy. The incidence of PE has been increasing in the United States, especially among pregnant women from disadvantaged socioeconomic populations, highlighting a need in health disparities research. Her aim is to utilize available genotype and clinical data to create and test a validated multiple logistic regression risk model for PE to examine the genetic and non-genetic determinants that contribute to PE disease risk. She is aware that there is a dearth of genetics studies with AI research participants, partially due to historical and cultural incongruities in establishing informed consent. She has a distinct opportunity to examine the ethical complexities of informed consent in an American Indian population. She presents a genetic, epidemiologic, and bioethical multifaceted approach towards investigating the impact of PE in American Indian women.
September 13, 2022
Time TBD
Zoom and location information to come
Janitza Montalvo-Ortiz
Yale University
Title to come
Janitza Montalvo-Ortiz research interests include the study of the genetic and epigenetic mechanisms associated with psychiatric disorders. She investigates how trauma-related events increase the vulnerability of developing mental disorders later in life.
November 8th, 2022
Time TBD
Zoom and location information to come
Thomas Fernandez
Yale University
Genetic studies of Obsessive-Compulsive and related disorders.
Thomas Fernandez is a child psychiatrist and psychiatric geneticist who has an active clinical practice and research laboratory. A faculty member at Yale Child Study Center and the Department of Psychiatry, his research efforts include the following investigations into developmental neuropsychiatric disorders: Discovering genetic mutations in Tourette syndrome, motor stereotypies, obsessive-compulsive disorder, ADHD, and anxiety disorders using next generation DNA sequencing (whole genome and exome), and using these discoveries to identify treatment targets. Discovering epigenetic marker variation in these disorders. Clinical trials of new behavioral and medication treatments.

 

Past talks

June 14, 2022
 
 
C. Eduardo Guerra Amorim
California State University Northridge
Paleogenomic Insights into Human History and Adaptation
C. Eduardo Guerra Amorim is a population geneticist interested in human evolution, anthropology, medical genetics, and in leveraging large datasets to contribute to the understanding of the biology of our species and of its closest relatives. Amorim’s research explores the interplay between demography, mutation, natural selection, and culture in determining the patterns of genetic diversity of human populations and how it impacts human health and evolution. Amorim works with African-Brazilian communities, indigenous populations, and, lately, has been working with large, public genomic databases from humans and other species.
May 17, 2022
 
 
Dr. Alejandra Rodriguez Ramirez
Department of Pharmacogenetics
Ramón de la Fuente Muñiz National Institute of Psychiatry
Imaging Genetics of Mood Disorders
 
April 12, 2022
 
 
Vanessa Goncalves
Centre for Addiction and Mental Health
Evidence of mitochondrial genetic association in the risk for schizophrenia
Vanessa Gonçalves has a multidisciplinary background in genetics, molecular biology, statistics, and epidemiology. Her research interests lie in advancing research on the role of mitochondrial gene variants in the risk for, and phenomenology of, neuropsychiatric disorders. Her research portfolio also includes pharmacogenetic studies focusing on the mitochondrial system. Her findings are very translatable into important medical improvements, such as new biomarkers, reduced side effects/medication failure, enhanced diagnostics, and better therapies for psychiatric patients.
March 15, 2022
 
 
Paola Giusti-Rodriguez
University of Florida
The LatinX Genomics Consortium: Advancing Psychiatric Genomics in Latinx Populations
Paola Giusti-Rodriguez grew up in San Juan, Puerto Rico, where she earned a BS in Biology at the University of Puerto Rico-Rio Piedras. She completed her PhD in Cell and Developmental Biology at Harvard University, where her doctorate research focused on studying the molecular basis of neurodegeneration. She employed the multi-parental Collaborative Cross mouse population to better understand antipsychotic side effects. Her work lies at the intersection between neuroscience and functional genomics, and she aims to integrate the tools and techniques of these fields to shed light on the genetics of neuropsychiatric disorders.